Reverse Micelle Encapsulation of Membrane-Anchored Proteins for Solution NMR Studies  by Valentine, Kathleen G. et al.
Structure
Ways & MeansReverse Micelle Encapsulation
of Membrane-Anchored Proteins
for Solution NMR Studies
Kathleen G. Valentine,1 Ronald W. Peterson,1 Jamil S. Saad,2 Michael F. Summers,2 Xianzhong Xu,3 James B. Ames,3
and A. Joshua Wand1,*
1Johnson Research Foundation and Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia,
PA 19104-6059, USA
2Howard Hughes Medical Institute and Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, Baltimore,
MD 21250, USA
3Department of Chemistry, University of California, Davis, Davis, CA 95616, USA
*Correspondence: wand@mail.med.upenn.edu
DOI 10.1016/j.str.2009.11.010SUMMARY
Perhaps 5%–10% of proteins bind to membranes
via a covalently attached lipid. Posttranslational
attachment of fatty acids such as myristate occurs
on a variety of viral and cellular proteins. High-resolu-
tion information about the nature of lipidated pro-
teins is remarkably sparse, often because of solu-
bility problems caused by the exposed fatty acids.
Reverse micelle encapsulation is used here to study
two myristoylated proteins in their lipid-extruded
states: myristoylated recoverin, which is a switch in
the Ca2+ signaling pathway in vision, and the myris-
toylated HIV-1 matrix protein, which is postulated
to be targeted to the plasma membrane through its
binding to phosphatidylinositol-4,5-bisphosphate.
Both proteins have been successfully encapsulated
in the lipid-extruded state and high-resolution NMR
spectra obtained. Both proteins bind their activating
ligands in the reverse micelle. This approach seems
broadly applicable to membrane proteins with
exposed fatty acid chains that have eluded structural
characterization by conventional approaches.
INTRODUCTION
Covalent attachment of fatty acids such as myristate and palmi-
tate occurs on a wide variety of viral and cellular proteins (Resh,
1999). Myristate, a 14 carbon saturated fatty acid, and palmitate,
a 16 carbon saturated fatty acid, commonly serve as key
elements of membrane targeting and anchoring of proteins.
Reversible membrane binding, controlled through triggered
exposure of lipid anchors, is central to protein-protein interac-
tions mediating signal transduction at the membrane (Casey,
1995). Lipid anchors are also now thought to be critical to the
exit of viruses from the eukaryotic cell (Maurer-Stroh and Eisen-
haber, 2004). For example, the coupled interaction of fatty acids
covalently attached to the HIV matrix protein with the membrane
and phosphoinositides embedded in target membranes isStructure 1thought to be central to its localization to the plasma membrane,
which in turn begins the assembly of the immature virus (Ono
et al., 2004; Saad et al., 2006). Accordingly, this initiation of virion
assembly is argued to be a prime candidate for pharmaceutical
intervention (Lindwasser and Resh, 2002). Structural knowledge
of this process would be of obvious utility. However, detailed
characterization of the structural features of the HIV-1 myristoy-
lated matrix protein (MA[+myr]), both by itself and in com-
plex with phosphatidylinositol-4,5-bisphosphate (PI[4,5]P2), has
been frustrated by the poor solution properties of both the
MA(+myr) protein and PI(4,5)P2 (Saad et al., 2006). Often what
is done is to simply remove the portion of the protein that carries
the lipid anchor, leaving a highly soluble and well-behaved
protein. This, however, obviously precludes examination of the
role of the anchor itself and the interaction of the anchored
protein with molecules presented by the membrane. A review
of the Protein Data Bank (PDB) reveals that high-resolution infor-
mation about the nature of lipidated proteins is remarkably
sparse, perhaps because of this inherent difficulty. The classic
and, one might argue, only structurally well-defined lipid anchor
switch is that of recoverin, which shows a calcium-dependent
exposure of a modified myristoyl group (Ames et al., 1997;
Tanaka et al., 1995). Recoverin(+myr) is a membrane-associated
protein that reacts to the influx of Ca2+ to extrude the hydro-
phobic myristoyl chain into the rod outer segment membranes.
The structural characterization ofmyristoylated recoverin (recov-
erin[+myr]) in the Ca2+-saturated state has also proved elusive
due to the limitations imposed by aggregation.
In an effort to overcome many of the difficulties presented
by the poor solution behavior of lipidated proteins in the
membrane-anchored state, we have adapted the reversemicelle
as a surrogate for the membrane bilayer in order to enable high-
resolution structural studies by solution NMRmethods. Over the
past decade there has been significant progress in the prepara-
tion of soluble proteinmolecules encapsulated within the protec-
tive water core of a reverse micelle dissolved in a low-viscosity
solvent such as the liquid alkanes (Peterson et al., 2005a,
2005b; Wand et al., 1998). The low-viscosity solvent allows for
sufficiently fast tumbling of the reverse micelle particle to signif-
icantly improve the NMR relaxation properties of the protein
(Peterson et al., 2005a; Wand et al., 1998). This new approach
is illustrated with the two myristoylated proteins discussed8, 9–16, January 13, 2010 ª2010 Elsevier Ltd All rights reserved 9
Figure 1. Reverse Micelle Encapsulation of Lipidated Proteins for
Solution NMR
Schematic illustration of the structure of a reverse micelle surfactant assembly
hosting a lipidated protein. A ribbon representation of the NMR structure of
HIV-1 MA(myr) (Doyle et al., 1998) is shown. The surfactant CTAB (orange)
cosolubilizes with hexanol (green) to form the reverse micelle shell. The myris-
toylated protein HIV-1 MA(+myr) inserts into the aqueous interior with the acyl
chain extruded into the hydrophobic surfactants. The reverse micelle particle
is solvated in a compatible low-viscosity solvent such as the short-chain
alkanes (Wand et al., 1998). This sample is designed to avoid the poor solution
behavior of lipidated proteins that often defeats detailed solution NMR studies.
Structure
Solution NMR Studies of Membrane-Anchored Proteinsabove: recoverin(+myr) and the HIV-1 MA(+myr). Both proteins
have been successfully encapsulated in the lipid-extruded state
and high-resolution NMR spectra have been obtained. Both
proteins can be directly titrated with their natural activating
ligands in the reverse micelle and their interactions followed
by high-resolution NMR. In the case of the HIV-1 MA(+myr),
chemical shift mapping identifies the location of the PI(4,5)P2
binding site.
RESULTS
Encapsulation of myristoylated proteins within a surfactant
system solvated in an alkane solvent proceeded as suggested
by encapsulation protocols for water-soluble proteins (Babu
et al., 2003; Lefebvre et al., 2005; Peterson et al., 2005b; Shi
et al., 2005; Wand et al., 1998). The caveat for recoverin(+myr)
and the HIV-1 MA(+myr) protein is the behavior of the hydro-
phobic myristoylate anchor. In free aqueous solution, both
proteins show ligand-dependent exposure of the covalently
attached myristoyl group, which generally complicates the
solution behavior of both proteins in the putative membrane-
anchored state where the myristoyl group is extruded. The
binding of calcium to recoverin(+myr) results in exposure of the
otherwise buried myristoyl group (Ames et al., 1995, 1997;
Tanaka et al., 1995). Similarly, the specific binding of PI(4,5)P2
to the HIV-1 MA(+myr) results in extrusion of the largely seques-
tered myristoyl group (Saad et al., 2006). It is predicted that the
reverse micelle surfactant shell will provide a solubilizing envi-
ronment for the myristoyl group and will therefore compete
with the hydrophobic interior of the soluble protein for the lipid
group, even in the absence of the ligand (Figure 1). This is indeed
the case for both proteins.
Encapsulation of Recoverin(+Myr)
We were unable to find conditions for direct encapsulation of
calcium-saturated recoverin(+myr), perhaps because Ca2+-
bound recoverin in solution tends to preaggregate, which might
prevent subsequent encapsulation. In the absence of calcium in
free solution, the myristoyl tail is sequestered and the protein
is well behaved. The maximum concentration tolerated was
2 mM before aggregation of the myristoylated protein was
evident. The identification of optimal encapsulation conditions
for recoverin(+myr) began with the selection of the cetyltrimethy-
lammonium bromide (CTAB) and hexanol surfactant system
(Lefebvre et al., 2005) as the most probable success for a myris-
toylated protein, with an acidic pI of 5.3. The preliminary results
indicated mixed states of the encapsulated recoverin(+myr),
likely resulting from myristoyl-extruded and myristoyl-seques-
tered forms. The aqueous protein buffer conditions were modi-
fied to include 1 mM ethylene glycol tetraacetate (EGTA) to
ensure removal of any free Ca2+ ions from the solution, thereby
selecting the myristoyl-sequestered state and limiting any
protein aggregation. The concentration of NaCl was increased
to 100 mM to further reduce the propensity to aggregate at the
high protein concentration used. Encapsulation of the protein
in this buffer system into CTAB/hexanol reverse micelles
resulted in a largely disordered state (Figure 2B). The spectrum
is characterized by broad crosspeaks of extremely low intensity,
indicative of a dynamic equilibrium of a mixture of states that10 Structure 18, 9–16, January 13, 2010 ª2010 Elsevier Ltd All rightsundergo exchange on the chemical shift timescale. Addition of
Ca2+ to the encapsulated recoverin by direct injection of
a concentrated solution of calcium chloride results in a more
homogeneous protein state, apparently due to stabilization by
the binding of Ca2+ to the protein (Figure 2). There is no evidence
of aggregation in the reverse micelle encapsulated state of the
Ca2+-bound recoverin(+myr). Final optimizations were directed
at maximizing protein concentration in the reverse micelle.
Surfactant concentration, aqueous solution protein concentra-
tion, and water loading are the adjustable parameters. The total
reverse micelle assembly size (correlation time) is also a consid-
eration for spectroscopic success. The best signal-to-noise
spectra were obtained with 200 mM CTAB, a starting protein
concentration of 2.2 mM, and a water loading, Wo, of 25. The
resulting protein concentration in the reverse micelle solution
was 180 mM recoverin(+myr). The pentane solution of encapsu-
lated calcium-saturated recoverin is stable for months at room
temperature. Other surfactant systems examined included the
triple-surfactant system lauryldimethylamine oxide (LDAO), do-
decyltetraethylene glycol ether (C12E4), and sodium bis(2-ethyl-
sulfosuccinate) (AOT) (Peterson et al., 2005b). This surfactant
system was successfully applied to the encapsulation of flavo-
doxin (Lefebvre et al., 2005), which also has a low pI, but failed
to successfully encapsulate recoverin(+myr) in a folded state.reserved
Figure 2. Encapsulation of Myristoylated Recoverin
15N HSQC spectra of (A) recoverin(+myr) in aqueous buffer in the Ca2+-free apo state; (B) Ca2+-free recoverin in CTAB/hexanol reverse micelles; and (C) Ca2+-
bound state of recoverin in CTAB/hexanol reverse micelles. The spectra in (B) and (C) are the identical sample without and with Ca2+ collected with the same
number of transients; the contour threshold is five times lower in (B). The increased sensitivity and spectral dispersion of the Ca2+-bound state in reverse micelles
is a clear demonstration of the folding of encapsulated recoverin(+myr) with the addition of Ca2+. The boxes include crosspeaks that are followed during the titra-
tion of Ca2+ into reverse micelles shown in Figure 3.
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tively titrated with calcium and recovers an 15N HSQC spectrum
consistent with the native structure in free solution. Notably, the
very low intensities of crosspeaks in the spectrum of the apo
state are converted to a high-intensity spectrum having the
anticipated signal-to-noise ratio (Figure 2). This unusual result
is most consistent with the apo state being composed of a
dynamic mixture of structures (including lipid-sequestered and
-extruded forms) that interconvert on the chemical shift differ-
ence timescale. This effect is nicely illustrated by two glycine
residues, G79 and G115, that participate in the turn region of
the calcium-loaded EF hands and have two characteristic upfield
shifted amide N-H correlations in the calcium-saturated state.
These crosspeaks can be used to follow the binding of calcium
to the protein (Figures 3A–3E). Binding of calcium stabilizes the
form of the protein with an extruded lipid group (Ames et al.,
1997). At a Ca2+:recoverin(+myr) stoichiometry of 2:1, weak
signals begin to appear for these two glycine residues and
increase upon subsequent addition of calcium while their chem-
ical shifts remain constant. This demonstrates that the Ca2+-
binding exchange rate is much slower than the chemical shift
difference timescale and is therefore consistent with high-affinity
and functional Ca2+ binding under these conditions (see also
Figure S1 available online).
The behavior of the tryptophan indole N-H chemical shift
correlations also inform on the extensive dynamic averaging in
the encapsulated apo state of the protein. In the absence of
calcium, there is a single weak signal due to one or more indole
N-H correlations of W31, W156, and W104. We also ascribe this
residual, broad signal to the heterogeneousmixture of structures
of the encapsulated apo state of recoverin(+myr) that intercon-
vert on the chemical shift difference timescale (Figures 3F–3J).
As calcium is added, this broad crosspeak disappears and three
sharp indole N-H crosspeaks arise. The indole N-H crosspeak of
W31 is the first to be sufficiently populated to appear above theStructure 18noise floor, at a Ca2+:recoverin(+myr) stoichiometry of 1.5:1.0,
whereas the indole N-H correlations of W156 and W104 appear
at slightly higher calcium concentrations. The intensity initially
appears slowly, as the protein competes with the residual free
EGTA for the added calcium, then builds up in a linear stoichio-
metric fashion with added Ca2+. This accounts for the greater
than stoichiometric 2:1 Ca2+:recoverin(+myr) plateau of the titra-
tion curve at 7.5:1 Ca2+:recoverin(+myr) (Figure 3). An endpoint
of the titration is reached where further addition of calcium
does not result in additional signal intensity. At very high calcium
concentrations, corresponding to a greater than 10:1 Ca2+:reco-
verin(+myr) molar ratio, the excess calcium apparently disrupts
the stability of the reverse micelle assembly and a catastrophic
loss of sample integrity ensues.
Encapsulation of the HIV-1 MA(+Myr)
Encapsulation conditions have been developed for the
N-terminal myristoylated matrix protein which mediates mem-
brane binding by an allosteric PI(4,5)P2-dependent myristoyl
switch mechanism (Saad et al., 2006). Direct determination of
the structure of the native PI(4,5)P2-bound state of the MA(+myr)
domain has been precluded by insolubility problems and by the
tendency of native PI(4,5)P2 to form high molecular weight
aggregates in solution. Recombinant MA proteins that contain
(MA[+myr]) or lack (MA[myr]) the N-terminal myristoyl group
were encapsulated into reverse micelles using the CTAB/hexa-
nol surfactant system in pentane. The HIV-1 MA(+myr) protein
has a basic pI of 9.1. Attempts to encapsulate the HIV-1
MA(+myr) with either the acidic surfactant AOT or a triple-surfac-
tant mixture containing AOT:CTAB:LDAO proved fruitless.
Although the MA protein encapsulated, it was unfolded in both
surfactant systems. In contrast, the CTAB/hexanol surfactant
system produced an encapsulated folded myristoylated protein
giving an 15N HSQC spectrum indicative of a folded protein.
Encapsulation conditions were then optimized for maximum, 9–16, January 13, 2010 ª2010 Elsevier Ltd All rights reserved 11
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Figure 3. Titration of Recoverin with Ca2+ in Reverse Micelles
The 15NHSQC spectra of recoverin(+myr) in CTAB/hexanol reversemicelles in (A)–(E) are titration points following the amide N-H correlations of residuesG79 and
G115 in the native state with the addition of Ca2+. Themolar ratios of Ca2+:recoverin(+myr) are indicated above the panels. (F)–(J) The disappearance of the indole
N-H correlations of the tryptophan side chain in the disordered apo state and the appearance of their counterparts in the calcium-saturated state are shown. The
molar ratios are the same as in the top panels. The full spectra are shown in Figure S3.
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Solution NMR Studies of Membrane-Anchored Proteinsprotein concentration. A maximum protein concentration in
aqueous buffer of 4 mM could be maintained for a time sufficient
for injection. Using a surfactant concentration of 200 mM CTAB
and 8.5% (v/v) hexanol and a Wo of 25 gave a final protein
concentration of 180 mM. The 15N HSQC spectrum of encapsu-
lated MA(+myr) is shown in Figure 4 and is compared to the
aqueous spectrum of MA(+myr) and MA(myr) in Figure S2.
Except for a few resonances associated with surface residues
that may have chemical shift perturbations due to electrostatic
interactions with the surfactant shell, the backbone amide N-H
chemical shifts of the encapsulated MA(+myr) protein are
remarkably similar to those of the free-solutionMA(myr) protein
(Figure 4), which clearly indicates that the myristoyl group of the
former leaves its hydrophobic pocket on the protein when placed
into the reverse micelle assembly. The amide N-H chemical shift
correlations were therefore initially assigned by reference to the
15N/1H chemical shifts reported for the HIV-1 MA(myr) in free
aqueous solution (Massiah et al., 1994) and then corroborated
using an 15N NOESY HSQC spectrum of the encapsulated pro-
tein and the main-chain directed resonance assignment
approach (Wand and Nelson, 1991).
Titration of the MA(+myr) protein with its membrane-targeting
ligand 1-stearoyl-2-arachidonyl-sn-glycero-3-phosphoinositol-
4,5-bisphosphate in free solution results in degradation of the
NMR performance of the protein due to severe line broadening
(Saad et al., 2006). As mentioned above, this is due, in part, to
the tendency of native PI(4,5)P2 to form micelles in water.
PI(4,5)P2 is insoluble in alkanes but is solubilized by CTAB/hex-
anol reverse micelles. This allows the MA(+myr) to be probed
for the binding of the PI(4,5)P2 ligand. The binding of PI(4,5)P212 Structure 18, 9–16, January 13, 2010 ª2010 Elsevier Ltd All rightsinto the MA(+myr) was followed by 15N HSQC spectra (Fig-
ure 5A). Several MA(+myr) amide N-H crosspeaks can be seen
to shift upon binding of PI(4,5)P2, but most remain relatively
unperturbed (see Figure S3). The continuous shifting of selected
resonances indicates specific binding that is in fast exchange on
the NMR chemical shift timescale (Figure 5). The titration does
not plateau (saturate) at the highest molar ratio of PI(4,5)P2:
MA(+myr) of 5.5:1 that could be reached. Unfortunately, the
reverse micelle assembly becomes unstable at higher concen-
trations of PI(4,5)P2. The amide sites that show significant shifts
are indicated in red in the backbone ribbon diagram of the HIV-1
MA(myr) NMR structure of Summers and coworkers (Massiah
et al., 1994) (Figure 5B). The binding is clearly localized at the
basic surface patch containing the turn connecting helices III
and IV, consistent with solution-state studies using soluble
PI(4,5)P2 analogs that contain truncated acyl chains.DISCUSSION
Reverse micelle encapsulation appears to provide a simple and
direct route to the detailed characterization of myristoylated
proteins in their lipid-extruded membrane-anchored state.
Under the surfactant and water compositions used here, the
reverse micelles contain on average several thousand water
molecules. The quality of the spectra that are obtained for
encapsulated calcium-saturated recoverin(+myr) and the HIV-1
MA(+myr) are consistent with only one protein molecule in
a reverse micelle. Higher occupancy would lead to severely
broadened resonance lines (Wand et al., 1998).reserved
Figure 4. Encapsulation of the Myristoylated HIV-1 Matrix Protein
(A) 15N HSQC spectrum of HIV-1 MA(+myr) in CTAB/hexanol reverse micelles. Assigned amide correlations are labeled.
(B) The chemical shift differences between amide N-H correlations in the aqueous HIV-1 MA(myr) spectrum and the corresponding resonances in the HIV-1
MA(+myr) protein encapsulated in CTAB/hexanol reverse micelles are plotted. The 15N chemical shift differences have been scaled by a factor of 10 to reflect
the difference in gyromagnetic ratios of 1H and 15N. See Figure S4 for overlays of the full spectra.
Structure
Solution NMR Studies of Membrane-Anchored ProteinsThe use of reverse micelle encapsulation to study lipidated
proteins should prove highly complementary to those involving
use of aqueous detergent micelles or isotropic bicelles. A partic-
ular advantage of the reverse micelle approach is the ability to
employ low-viscosity fluids such as liquid ethane that preserve
favorable relaxation properties and thereby avoid the necessity
for extensive deuteration (Peterson et al., 2005a). On the other
hand, the continuing development of the more slowly tumbling
isotropic bicelle as a vehicle for studying membrane proteins in
a true bilayer lipid environment will provide support for studies
undertaken in the reverse micelle single-layer shell (Kim et al.,
2009).
The two example proteins studied here have quite distinct bio-
logical roles and contrasting ligand triggers for membrane
anchoring. Recoverin employs the water-soluble calcium cation
to initiate membrane anchoring that subsequently results in
activation of the G-protein-mediated signaling cascade. The
calcium-activated state of the protein is fully folded while
anchored to the reverse micelle surfactant shell. Interestingly,
the presumably functionally inappropriate lipid-extruded apo
state of the protein is promoted by encapsulation but results in
an ensemble of states. The encapsulation of the protein appar-
ently sufficiently modifies the equilibrium between the structures
of recoverin(+myr) that sequester or extrude the myristoyl group
such that the latter is favored. This generates a dynamic mixture
of sequestered and extruded forms in the apo state andStructure 18suggests that this mixture is dynamically exchanging in the
absence of calcium, which would be consistent with the
calcium-mediated signaling switch of the protein. It is interesting
to note that the encapsulated Ca2+-free recoverin(+myr) exhibits
very broad NMR resonances because the dynamic exchange of
sequestered and extruded forms of the apo protein causes
structural changes that result in chemical shift differences that
are not averaged, thereby causing exchange broadening. The
confined space of the reverse micelle apparently slows the
dynamical interconversion of the ensemble of states such that
no single (or average) spectral signature dominates. A similar
effect is seen during the process of protein cold denaturation
in reversemicelles (Babu et al., 2004; Pometun et al., 2006;Whit-
ten et al., 2006).
The equilibrium between the sequestered and solvent-
exposed states of the myristoylated HIV-1 matrix protein is
also significantly altered by encapsulation and is pushed toward
what is putatively the membrane-anchored structure of the
protein. In contrast to recoverin(+myr), however, this state of
the myristoylated MA protein is highly structured and is, by
chemical shift analysis, closely similar to the unmyristoylated
form of the protein, that is, the myristoyl group is fully extruded
from the protein. This behavior is consistent with the idea that
the MA protein needs to probe the identity of a given membrane
by repetitive insertions of the anchor followed by binding of the
plasma membrane-specific PI(4,5)P2 recognition element. In, 9–16, January 13, 2010 ª2010 Elsevier Ltd All rights reserved 13
Figure 5. Titration of the Encapsulated HIV-1 MA(+Myr) with PI(4,5)P2
(A) Expansions of the 15N HSQC spectra of the HIV-1 MA(+myr) in CTAB/hexanol reverse micelles illustrating amide N-H correlations that shift upon titration with
PI(4,5)P2. The molar ratios of PI(4,5)P2:MA(+myr) are color coded as indicated.
(B) A ribbon representation of the solution NMR structure of the HIV-1MA(myr) (Massiah et al., 1994) (PDB ID code 2HMX) is shownwith the backbone colored in
red at sites that demonstrate significant shifts in the HSQC spectra on titration with PI(4,5)P2. The figure was drawn with PyMOL (DeLano, 2002). The full spectra
are shown in Figure S5.
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Solution NMR Studies of Membrane-Anchored Proteinsthis model, the protein would naturally be stable and structured
in both the soluble sequestered and membrane-anchored
extruded states. Whether this distinction persists across the
many different lipidated proteins remains an interesting and
exciting question.
Analysis of the chemical shift perturbations brought about by
the binding of PI(4,5)P2 to MA(+myr) indicates a similar but not
identical interaction surface to that highlighted by the binding
of a more water-soluble PI(4,5)P2 analog (Saad et al., 2006).
Detailed structural studies of the encapsulated MA(+myr):
PI(4,5)P2 complex described here are ongoing and will be
reported elsewhere.
In conclusion, the results presented here suggest that the
reverse micelle particle has been successfully adapted to the
study of myristoylated proteins in the lipid-extruded state
using high-resolution solution NMR methods. The generality
of the encapsulation strategy for studying lipidated proteins
remains to be ascertained, especially with respect to the type
of membrane anchor employed. Although some limitations are
apparent, quite detailed structural investigations are clearly
made feasible by this approach and include characterization of
the structural basis for the interaction of ligands with proteins
in themembrane-anchored state. Both water-soluble and -insol-
uble ligands can be employed. Although the confined space
effects of the reverse micelle complicate quantitative interpreta-
tion of observed binding phenomena, the ability to investigate
the interactions of lipid-anchored proteins with small ligands
in structural detail is a significant and very useful capability.
Furthermore, the performance of proteins encapsulated in
reverse micelles dissolved in alkane solvents of modest viscosity
such as pentane can be directly reproduced in very low viscosity14 Structure 18, 9–16, January 13, 2010 ª2010 Elsevier Ltd All rightsliquefied ethane (Peterson et al., 2005a) and thereby take advan-
tage of the reversemicelle approach as originally envisaged, that
is, improve the relaxation properties of the protein such that the
full power of solution NMR can be applied. The initial results
presented here also provide the foundation for investigation of
larger protein complexes associated with membrane-anchored
protein cores. It should also be noted that the very simple reverse
micelle surfactant system used here has quite different steric and
electrostatic properties from a natural membrane bilayer. It is
useful to begin consideration of reverse micelle surfactant
systems to mimic the basic properties of membrane bilayers
and ‘‘membrane rafts’’ (Pike, 2006).EXPERIMENTAL PROCEDURES
Encapsulation of Recoverin(+Myr) in Reverse Micelles
Myristoylated recoverin was prepared and purified from unmyristoylated
protein by HPLC as previously described (Ames et al., 1994). The purified
protein was >95% myristoylated as judged by electrospray mass spectrom-
etry. A 0.5 mM solution of [15N]recoverin(+myr) was buffer exchanged and
concentrated using a 10K Amicon ultra-15 cell into 10 mM Tris, 100 mM
NaCl, 1 mM dithiothreitol, 1 mM EGTA (pH 8.0). The maximum concentration
tolerated was 2 mM before aggregation of the myristoylated protein
was evident. The identification of optimal encapsulation conditions for recov-
erin(+myr) is summarized in themain text. The reversemicelle slurry of 200mM
CTAB, 8.5% (v/v) hexanol in d12-pentane was prepared in a glass vial. The
concentrated protein solution (68 ml) was injected at a calculated Wo of
25 (H2O:CTAB molar ratio) with a Pipetman into the reverse micelle slurry
and vortexed. With the addition of the aqueous protein solution, the reverse
micelle assembles and the slurry clears in a matter of a few minutes with
only gentle agitation. The solution was transferred to a Wilmad screw cap
NMR tube for data acquisition. The reversemicelle solution was 180 mM recov-
erin(+myr), 200 mM CTAB, 8.5% (v/v) hexanol in d12-pentane. Encapsulatedreserved
Structure
Solution NMR Studies of Membrane-Anchored Proteinsrecoverin(+myr) was titrated with calcium by direct addition of aliquots
of 100mMCaCl2 in water. The sample was briefly vortexed to facilitate mixing.Encapsulation of the HIV-1 MA(+Myr)
15N-labeled HIV-1 MA(+myr) protein was prepared and purified from unmyris-
toylated protein as described previously (Massiah et al., 1994; Tang et al.,
2004). The purity of the myristoylated protein was confirmed by electrospray
mass spectrometry. The 15N-labeled HIV-1 MA(+myr) was buffer exchanged
and concentrated using a 15K Amicon ultra-4 cell into 1/10 the NMR buffer
concentration: 2 mM sodium phosphate, 4 mM NaCl (pH 6.5). The maximum
concentration tolerated was0.4 mM before aggregation of the myristoylated
protein was evident. A protein aliquot of 400 ml was then lyophilized. The
lyophilized aliquot was then rehydrated in 1/10 the volume, 40 ml, resulting
in a 20 mM phosphate, 40 mM NaCl buffered protein solution. The reverse
micelle slurry of 200 mM CTAB, 10% (v/v) hexanol in d12-pentane was
prepared in a glass vial. A sufficient volume of the concentrated protein
solution (40 ml) to give a calculated water loading (Wo) of 15 (H2O:CTAB
molar ratio) was injected into the reverse micelle slurry and vortexed.
The initially cloudy solution cleared in a few minutes. The reverse micelle solu-
tion in d12-pentane was 470 mM HIV-1 MA(+myr), 200 mM CTAB, 10% (v/v)
hexanol and was transferred to a Wilmad screw cap tube for NMR data
acquisition.Titration of Encapsulated HIV-1 MA(+Myr) with PI(4,5)P2 18:0/20:4
Lipid
The titration with PI(4,5)P2 is somewhat complicated by the lack of solubility of
this lipid in either water or alkane solvent. The PI(4,5)P2 (Avanti Polar Lipids)
was first dissolved in CHCl3:MeOH:H2O 20:9:1 (v/v/v) at a concentration of
600 mM. Aliquots were then dried onto the surface of a glass vial with a stream
of argon gas to form a thin film of the lipid. Solutions of encapsulatedMA(+myr)
in CTAB/hexanol reverse micelles were vortexed in the vial containing the
thin film and the lipid was solubilized into the reverse micelle assembly. The
titration proceeded in increments of 0.5:1.0 to a final molar ratio of 5.5:1.0.
Raising the concentration of lipid above 1 mM in the 200 mM CTAB solution
causes degradation of the reverse micelle solution resulting in extensive
precipitation.NMR Spectroscopy
15N HSQC spectra were collected on Bruker Avance III NMR spectrometers
operating at 750 and 600 MHz (1H). Three-dimensional 15N NOESY HSQC
spectra were collected on the [15N]recoverin(+myr) and 15N-labeled HIV-1
MA(+myr) reverse micelle samples using an NOE mixing time of 110 ms. The
d12-pentane was used to lock the spectrometer. Both spectrometers were
equipped with a cryogenically cooled probe that provided excellent signal to
noise on the 70–180 mM encapsulated protein solutions owing to their optimal
low conductivity (Flynn et al., 2000). FELIX was used to process the data and
SPARKY (Goddard and Kneller, 2004) was used for data analysis.SUPPLEMENTAL INFORMATION
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